GILD: Income Statement for Gilead Sciences, Inc.

PERIOD ENDING		30-Sep-09	30-Jun-09	31-Mar-09	31-Dec-08
Total Revenue		1,801,389	1,647,155	1,530,460	1,428,205
Cost of Revenue		409,700	383,045	329,414	321,531

Gross Profit		1,391,689	1,264,110	1,201,046	1,106,674

	Operating Expenses
	Research Development	269,856	241,638	188,779	201,863
	Selling General and Administrative	227,427	261,411	203,951	193,665
	Non Recurring	-	-	-	-
	Others	-	-	-	-

	Total Operating Expenses	-	-	-	-


Operating Income or Loss		894,406	761,061	808,316	711,146

	Income from Continuing Operations
	Total Other Income/Expenses Net	14,017	12,923	4,158	19,038
	Earnings Before Interest And Taxes	908,423	773,984	812,474	732,553
	Interest Expense	17,217	18,484	16,671	2,871
	Income Before Tax	891,206	755,500	795,803	729,682
	Income Tax Expense	220,728	186,355	209,227	161,488
	Minority Interest	7,344	-	-	2,369

	Net Income From Continuing Ops	677,822	569,145	586,576	568,194

	Non-recurring Events
	Discontinued Operations	-	-	-	-
	Extraordinary Items	-	-	-	-
	Effect Of Accounting Changes	-	-	-	-
	Other Items	-	-	-	-


Net Income		677,822	569,145	586,576	568,194
Preferred Stock And Other Adjustments		(4,789)	2,253	2,536	-

Net Income Applicable To Common Shares		$673,033	$571,398	$589,112	$568,194

Add to Portfolio

Set Alert

Email to a Friend

•	Sector Analysis

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More